01

The signal is not the whole story

AI may help classify cases or surface safety signals, but a reviewer also needs to see the data considered, the algorithm and version used, and the reason a signal was raised or dismissed.

02

Integrity is already an operating expectation

Good pharmacovigilance practice and electronic-record controls place weight on attributable, time-stamped audit trails. A summary dashboard cannot replace the history of a particular case and its human review.

03

Preserve the decision path

At the point of use, capture the output, applied checks, escalation and final human action. That record helps teams revisit a safety decision when new information arrives.

Basis

EU Good Pharmacovigilance Practices · 21 CFR Part 11 §11.10(e) · EU GMP Annex 11 · Draft Annex 22